57014-02-5

Hazard Information

Questions And Answer

• Application

  Calcitonin primarily works by regulating the skeletal system, kidneys, and gastrointestinal tract, lowering blood calcium levels and improving or alleviating bone pain caused by osteoporosis.
  1. Effects on bones: Calcitonin inhibits bone autolysis and resorption, reducing calcium release from bones; simultaneously, bones continuously absorb calcium from the blood, lowering blood calcium levels. It also inhibits bone salt dissolution and transfer, inhibits bone resorption, increases bone turnover, and increases urinary excretion of calcium and phosphorus, thus lowering blood calcium and phosphorus levels. For patients with osteoporosis, this product can reduce continued bone loss and decrease the incidence of fractures.
  2. Inhibits the release of pain mediators, blocks their receptors, and increases β-endorphin release, resulting in peripheral and central analgesic effects.
  3. Effects on the kidneys: By inhibiting the reabsorption of calcium, phosphorus, and sodium by the renal tubules, it increases their excretion in urine, but does not lower blood calcium levels below the normal range, and has minimal effect on potassium and hydrogen ions. 4. Effects on the gastrointestinal tract: It can inhibit intestinal calcium transport and suppress the secretion of gastric acid, gastrin, and insulin. Clinically, calcitonin can be used to treat osteitis deformans, osteoporosis in the elderly, and hypercalcemia caused by bone metastases.;

Supplier

Related Products